August 26, 2022
FDA’s Gail Bormel to appear at CCH
FDA’s director of the Office of Compounding Quality and Compliance, Gail Bormel, has accepted APC’s invitation to attend Compounders on Capitol Hill. She’ll participate in a special interview-style session with APC CEO Scott Brunner on Wednesday afternoon, September 14, prior to Capitol Hill visits the next day.
In addition to FDA’s Bormel, the conference includes presentations by Ranking Member of the House Energy & Commerce Committee Cathy McMorris Rodgers (WA) and Senate HELP Committee member Senator Jacky Rosen (NV).
“I can’t think of a more urgent need for compounders to come to DC,” said Brunner. “The threat to compounded hormones, the ambiguity in CVM veterinary compounding GFI, and a potential opportunity for compounders to mitigate drug supply chain issues are all on the table. But none of those things will come about if our members don’t attend and brief their members of Congress.”
To learn more about CCH and to register, please click here.
